S. O. Francisco

Induction of poxviral immunity by synthetic MVA-based dual-antigen COVID-19 vaccine COH04S1

J. Zaia, D. Diamond, F. Chiuppesi, 2022, medRxiv.

Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants

Anna M. Acosta, P. Frankel, J. Zaia, 2022, iScience.

Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients

M. Romano, A. Jordan-Rios, Ricardo Campos, 2021, Trials.

Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial

A. Sette, P. Frankel, J. Zaia, 2022, The Lancet Microbe.